Altintas, A. Et Al. 2012. The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results. 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) , (Stockholm, Sweden), 752.

Altintas, A., Nalbantoglu, M., Celik, R. G. G., Adibnia, Y., Kursun, A., & Deniz, G., (2012). The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results . 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) (pp.752). Stockholm, Sweden

Altintas, A. Et Al. "The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results," 16th Congress of the European-Federation-of-Neurological-Societies (EFNS), Stockholm, Sweden, 2012

Altintas, A. Et Al. "The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results." 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) , Stockholm, Sweden, pp.752, 2012

Altintas, A. Et Al. (2012) . "The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results." 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) , Stockholm, Sweden, p.752.

@conferencepaper{conferencepaper, author={A. Altintas Et Al. }, title={The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results}, congress name={16th Congress of the European-Federation-of-Neurological-Societies (EFNS)}, city={Stockholm}, country={Sweden}, year={2012}, pages={752} }